Definium Therapeutics Inc. Common Shares vs XPO Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B), while XPO Inc. Common Stock trades at $183.65 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 4.6× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and XPO Inc. Common Stock for 1 Days on average.
| DFTX | XPO | |
|---|---|---|
Market Cap | $4.59B | $21.30B |
Volume | 2,103,937 | 897,705 |
Sector | Health | Industrials |
52-Week High | $48.45 | $228.37 |
52-Week Low | $10.68 | $123.66 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $24.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →